| CARLAT PUBLISHING

The new DSM-5 will change the way clinicians diagnose substance use disorders (SUD) and could have far-reaching consequences for patients seeking treatment and clinicians and organizations offering that treatment. Read More

Learn the motivation and reasoning behind the substance use disorders section of DSM-5 in this interview with chair of the substance use disorders workgroup, Charles P O’Brien, MD, PhD Read More

CBT Doesn’t Improve Effectiveness of Office-Based Buprenorphine Treatment

The ability of primary care and other office-based physicians to prescribe buprenorphine has more than doubled the capacity of the US healthcare system to treat patients addicted to prescription opioids and heroin. One barrier to expanding access to this treatment is that some physicians cite a lack of available counseling services as reason not to offer buprenorphine treatment in their offices. Read More

Medication Fact Book for Psychiatric Practice, Seventh Edition (2024)
The updated 2024 reference guide covering the most commonly prescribed medications in psychiatry.
READ MORE

General Psychiatry
Using SAMe In Clinical Practice with Garrett Rossi, MD
Read More

Addiction Treatment
Supervised Drug Consumption Sites
Once controversial, research clearly shows the benefit of these sites, and they have started opening in the United States.
Listen now